HLNHaleon plc
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−4% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −4% vs its 200-day average.
A token position, settled Sep 15, 2026, a few days of normal trading to cover. Up 42% since the previous count, up from 0.2% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How HLN is trading
Haleon plc is +3.0% over the past year while the S&P 500 is +18%: 15 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −4.2%
vs 200-day average · below trend, but not far
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- 16%
Below its 52-week high
Details›
- Last close2026-10-09
- $9.31
- 1 monthS&P 500 +2.7%
- +1.0%
- 1 yearS&P 500 +18%
- +3.0%
- vs 50-day average$9.56
- −2.6%
- 52-week high
- $11.12
- 52-week low
- $8.61
- Annualised volatility
- 23%
| Year | Return |
|---|---|
| 2026 (year to date) | −6.7% |
| 2025 | +7.8% |
| 2024 | +18% |
| 2023 | +4.2% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 2 of 4 | +0.93% |
| Feb | 4 | 3 of 4 | +3.7% |
| Mar | 4 | 3 of 4 | −1.0% |
| Apr | 4 | 2 of 4 | +0.69% |
| May | 4 | 1 of 4 | −0.13% |
| Jun | 4 | 2 of 4 | −1.1% |
| Jul | 4 | 3 of 4 | +4.4% |
| Aug | 5 | 2 of 5 | −1.4% |
| Sep | 5 | 3 of 5 | −2.4% |
| Oct | 5 | 3 of 5 | −0.80% |
| Nov | 4 | 3 of 4 | +5.9% |
| Dec | 4 | 2 of 4 | +3.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #12 of 41 by RyuScore